Search company, investor...
nanoTherics company logo


Founded Year



Series C | Alive

Total Raised


About nanoTherics

nanoTherics develops and commercialises magnetic nanoparticle-based products for the life-science sector. The company's scientific devices and reagents improve the uptake of biomaterials into cells, a process called transfection, to greatly facilitate research and development of gene-related diseases and disorders.

Headquarters Location

Innovation Centre 4 Keele University Science and Business Park, Keele

Staffordshire, England, ST5 5NL,

United Kingdom

+44 (0) 1782 409 700

Missing: nanoTherics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: nanoTherics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

nanoTherics Patents

nanoTherics has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Liver transplant recipients, Gene delivery, Molecular biology, Inflammations, Rare diseases


Application Date


Grant Date



Related Topics

Liver transplant recipients, Gene delivery, Molecular biology, Inflammations, Rare diseases



Latest nanoTherics News

Mercia Fund Management continues with EIS transactions by backing two technology businesses

Mar 27, 2013

Email a Friend Friend's email: * Send Venture capital fund manager Mercia Fund Management has chosen Warwick Audio Technologies and nanoTherics as its first Mercia Growth Fund 1 investments. Future sounds: Warwick Audio Technologies has developed thin speakers Date: 26 March 2013 Article: News Two EIS fund investments from Mercia Growth Fund 1 will go towards aiding the growth efforts of Warwick Audio Technologies and nanoTherics. Mercia Growth Fund 1 is described as the first hybrid fund offering EIS and SEIS investment opportunities and was launched in 2012 before hitting £2 million in size. New investment Warwick Audio Technologies develops an audio product which consists of a flat and flexible loudspeaker laminate. The investment made in the Coventry-based business will help with the delivery of 'key' commercial contracts in the ceiling speaker, audio visual and automotive sectors. Fellow new portfolio company nanoTherics develops and retails magnetic nanoparticle-based produces for the life science research industry. Its new capital will be used for the expansion of its sales infrastructure and products under development. Mark Payton, managing director of Mercia Fund Management , comments, 'Warwick Audio Technologies and nanoTherics are truly exciting and transformational businesses now rapidly expanding their growth on the back of substantial commercial progress. ' More on EIS and SEIS:

nanoTherics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

nanoTherics Rank

nanoTherics Frequently Asked Questions (FAQ)

  • When was nanoTherics founded?

    nanoTherics was founded in 2007.

  • Where is nanoTherics's headquarters?

    nanoTherics's headquarters is located at Innovation Centre 4, Staffordshire.

  • What is nanoTherics's latest funding round?

    nanoTherics's latest funding round is Series C.

  • How much did nanoTherics raise?

    nanoTherics raised a total of $1.8M.

  • Who are the investors of nanoTherics?

    Investors of nanoTherics include Mercia Asset Management, Catapult Ventures and WM Enterprise Investment Division.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.